ACCUSIGN TCA, BIOSIGN TCA, STAUS DS TCA

Radioimmunoassay, Tricyclic Antidepressant Drugs

PRINCETON BIOMEDITECH CORP.

The following data is part of a premarket notification filed by Princeton Biomeditech Corp. with the FDA for Accusign Tca, Biosign Tca, Staus Ds Tca.

Pre-market Notification Details

Device IDK980249
510k NumberK980249
Device Name:ACCUSIGN TCA, BIOSIGN TCA, STAUS DS TCA
ClassificationRadioimmunoassay, Tricyclic Antidepressant Drugs
Applicant PRINCETON BIOMEDITECH CORP. 4242 U.S. RT. 1 Monmouth Junction,  NJ  08852 -1905
ContactJemo Kang
CorrespondentJemo Kang
PRINCETON BIOMEDITECH CORP. 4242 U.S. RT. 1 Monmouth Junction,  NJ  08852 -1905
Product CodeLFG  
CFR Regulation Number862.3910 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-01-23
Decision Date1998-03-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.